← Back to All Filings

Labcorp CEO Sells $1.5M in Stock Under Pre-Arranged Trading Plan

Low SignificanceNovember 13, 2025 at 9:03:22 AM EST

LABCORP HOLDINGS INC.

$LH4CIK: 0000920148

Subscribe to track LH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Labcorp CEO Sells $1.5M in Stock Under Pre-Arranged Trading Plan

Company: LABCORP HOLDINGS INC. (LH) Form: 4 | Filed: 2025-11-13 Significance: Low

Insider: Schechter Adam H Title: President & CEO | Relationship: Director, Officer

Transaction: • Type: Sale • Shares: 5,745 • Price: $262.75 • Value: $1,509,994 • Owned After: 87,574

Key Insight: The sale was conducted under a pre-scheduled 10b5-1 plan, reducing its informational value. The transaction size is negligible compared to Labcorp's $21.65B market cap.

Market Context: This is a routine, planned sale by a top executive and represents a very small fraction (0.007%) of the company's outstanding shares.

Comprehensive Analysis

SEC Filing Analysis: LABCORP HOLDINGS INC. (LH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The President & CEO of Labcorp executed a minor, pre-planned sale of common stock valued at approximately $1.5 million.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to influence the stock price.

Company Information

FieldValue
CompanyLABCORP HOLDINGS INC.
Ticker SymbolLH
CIK0000920148
IndustryMedical Laboratories

Insider Information

FieldValue
NameSchechter Adam H
CIK0001376841
Title/PositionPresident & CEO
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-11
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved5,745
Price Per Share$262.75
Total Value$1,509,993.75
Shares Owned After87,574
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,509,993.75
% of Market Cap0.007%
Shares Transacted5,745
% of Shares Outstanding0.007%
Post-Transaction Ownership87,574 shares (0.105% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $21.65 billion, this $1.5 million sale is financially insignificant, representing a tiny fraction of the company's total value.
  • Ownership Concentration: The sale represents a minor reduction (approx. 6.15%) in the CEO's direct holdings and does not materially change his ownership stake, which remains at ~0.1% of outstanding shares.
  • Transaction Significance: The transaction falls well below the thresholds for moderate or high significance. Its small size relative to both market cap and shares outstanding indicates it is a routine portfolio adjustment rather than a strategic move based on inside information.

Additional Context

Transaction Notes

  • Special Circumstances: This sale was executed pursuant to a Rule 10b5-1 trading plan, which was established in advance. Such plans are used by insiders to sell stock over a predetermined period to avoid accusations of trading on non-public information. This significantly lowers the trade's informational value.
Topics:#InsiderTrading#SECFiling#Form4#Labcorp#LH#InsiderSell#StockMarket#Investing#CEO

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.